ILUMYA

Approval Id: 342f5c334ce82565
Drug Approval Canada Name: ILUMYA
Product Name: ILUMYA
Status: Marketed
Status Date: 2022-10-24
Original Market Date: 2021-08-04
Din: 02516098
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D , Prescription
Ahfs: 84:06.28
Atc Original: L04AC17 TILDRAKIZUMAB
Atc Name: l 04 ac 17
Aig Number: 0162907001
Company Name: SUN PHARMACEUTICAL INDUSTRIES LIMITED
Company Address: Sun House, Plot 201 B/1, Western Express Highway, Goregaon (E), Mumbai, Maharashtra, India, 400063
Company Detail Path: /organization/sun-pharmaceutical-industries-limited

TILDRAKIZUMAB

100 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

342f5c334ce82565

Type

Standard